Surgalign Holdings, Inc. provided revenue guidance for the year 2022. For the year, the Company anticipates full year revenue in the range of $83 million to $87 million.
Surgalign Holdings, Inc.
Equities
SRGA
US86882C2044
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
-9.49% | 31.38B | |
+25.35% | 8.33B | |
+33.25% | 4.27B | |
-35.85% | 2.47B | |
-9.44% | 1.65B | |
-13.39% | 1.5B | |
-32.84% | 1.07B | |
+7.80% | 974M | |
-37.56% | 840M |